Mitochondriotropic nanoemulsified genistein-loaded vehicles for cancer therapy

Methods in Molecular Biology

Volumn 1265, Issue , 2015, Pages 85-101

  Pham, Jimmy ^a   Grundmann, Oliver ^a   Elbayoumi, Tamer ^a  

^a NONE

Author keywords

Apoptosis; Caspase enzymes; Cytochrome c; Genistein; Isoflavone; Mitochondrial damage; Mitochondriotropic

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; DOXORUBICIN; GENISTEIN; LIPOSOME; ANTINEOPLASTIC AGENT; EMULSION; MICELLE; NANOPARTICLE; PROTEIN KINASE INHIBITOR;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; LABORATORY; LIPOSOMAL DELIVERY; MICELLIZATION; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; NANOEMULSION; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; EMULSION; FLUORESCENCE MICROSCOPY; METABOLISM; MICELLE; PROCEDURES; TUMOR CELL LINE;

NES;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; EMULSIONS; GENISTEIN; HUMANS; MICELLES; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; NANOPARTICLES; PROTEIN KINASE INHIBITORS;

EID: 84958672692     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2288-8_7     Document Type: Article

References (24)

1. Costantini P, Jacotot E, Decaudin D, Kroemer G (2000) Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst 92:1042–1053
2. Li Y, Upadhyay S, Bhuiyan M, Sarkar FH (1999) Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18:3166–3172
3. Baxa DM, Yoshimura FK (2003) Genistein reduces NF-kappa B in T lymphoma cells via a caspase-mediated cleavage of I kappa B alpha. Biochem Pharmacol 66:1009–1018
4. Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ, Barnes S (1995) Genistein suppresses mammary cancer in rats. Carcinogenesis 16:2833–2840
5. Buchler P, Gukovskaya AS, Mouria M, Buchler MC, Buchler MW, Friess H, Pandol SJ, Reber HA, Hines OJ (2003) Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isofl avonoid. Pancreas 26:264–273
6. Lazarevic B, Boezelijn G, Diep LM, Kvernrod K, Ogren O, Ramberg H, Moen A, Wessel N, Berg RE, Egge-Jacobsen W, Hammarstrom C, Svindland A, Kucuk O, Saatcioglu F, Tasken KA, Karlsen SJ (2011) Effi cacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebocontrolled, double-blind Phase 2 clinical trial. Nutr Cancer 63:889–898
7. Taylor CK, Levy RM, Elliott JC, Burnett BP (2009) The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutr Rev 67: 398–415
8. Yoshimura FK (2004) Genistein induces apoptosis via mitochondrial damage in acute lymphoblastic leukemia T-cell lines. Cancer Therapy 2:429–440
9. George J, Banik NL, Ray SK (2010) Genistein induces receptor and mitochondrial pathways and increases apoptosis during BCL-2 knockdown in human malignant neuroblastoma SK-N-DZ cells. J Neurosci Res 88:877–886
10. Phan V, Walters J, Brownlow B, Elbayoumi T (2013) Enhanced cytotoxicity of optimized liposomal genistein via specifi c induction of apoptosis in breast, ovarian and prostate carcinomas. J Drug Target 21:1001–1011
11. Yoon HS, Moon SC, Kim ND, Park BS, Jeong MH, Yoo YH (2000) Genistein induces apoptosis of RPE-J cells by opening mitochondrial PTP. Biochem Biophys Res Commun 276:151–156
12. Baxa DM, Luo X, Yoshimura FK (2005) Genistein induces apoptosis in T lymphoma cells via mitochondrial damage. Nutr Cancer 51:93–101
13. Merchant K, Kumi-Diaka J, Rathinavelu A, Esiobu N, Zoeller R, Hartmann J, Johnson M (2011) Molecular basis of the anti-cancer effects of genistein isofl avone in LNCaP prostate cancer cells. Funct Food Health Dis 1:91–105
14. Stancanelli R, Guardo M, Cannava C, Guglielmo G, Ficarra P, Villari V, Micali N, Mazzaglia A (2010) Amphiphilic cyclodextrins as nanocarriers of genistein: a spectroscopic investigation pointing out the structural properties of the host/drug complex system. J Pharm Sci 99:3141–3149
15. Cannava C, Crupi V, Ficarra P, Guardo M, Majolino D, Mazzaglia A, Stancanelli R, Venuti V (2010) Physico-chemical characterization of an amphiphilic cyclodextrin/genistein complex. J Pharm Biomed Anal 51:1064–1068
16. Trapp S, Horobin RW (2005) A predictive model for the selective accumulation of chemicals in tumor cells. Eur Biophys J 34:959–966
17. Horobin RW, Trapp S, Weissig V (2007) Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria. J Control Release 121:125–136
18. Pham J, Brownlow B, Elbayoumi T (2013) Mitochondria-specifi c pro-apoptotic activity of genistein lipidic nanocarriers. Mol Pharm 10:3789–3800
19. Weissig V (2005) Targeted drug delivery to mammalian mitochondria in living cells. Expert Opin Drug Deliv 2:89–102
20. Whaley WL, Rummel JD, Kastrapeli N (2006) Interactions of genistein and related isofl avones with lipid micelles. Langmuir 22: 7175–7184
21. Kwon SH, Kim SY, Ha KW, Kang MJ, Huh JS, Im TJ, Kim YM, Park YM, Kang KH, Lee S, Chang JY, Lee J, Choi YW (2007) Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery. Arch Pharm Res 30:1138–1143
22. Weissig V (2011) Mitochondrial delivery of biologically active molecules. Pharm Res 28:2633–2638
23. Jordan M, Nayel A, Brownlow B, Elbayoumi T (2012) Development and evaluation of tocopherol-rich argan oil-based nanoemulsions as vehicles possessing anticancer activity. J Biomed Nanotechnol 8:944–956
24. Mu L, Elbayoumi TA, Torchilin VP (2005) Mixed micelles made of poly(ethylene glycol)- phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 306:142–149